English - Global Alliance to Eliminate Lymphatic Filariasis

REPORT OF THE 6 TH GAELF MEETING, JUNE 2010
References
1. Cheun H-II, Kong Y, Cho S-H, Lee J-S, Chai J-Y, Lee J-S, Lee J-K, Kim T-S: Successful
control of lymphatic filariasis in the Republic of Korea. Korean J Parasitol 2009, 47:323-
335.
2. Cheun H-II, J-S, Lee, Cho S-H, Kong Y, Kim T-S: Elimination of lymphatic filariasis in the
Republic of Korea: an epidemiological survey of formerly endemic areas, 2002-2006.
Trop Med Internat Health 2009, 14:445-449.
3. Ottesen EA, Hooper PJ, Bradley M, Biswas G: The global programme to eliminate
lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008, Oct
8;2(10):e317.
4. Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA: The economic benefits
resulting from the first 8 years of the Global Programme to Eliminate Lymphatic
Filariasis (2000-2007). PLoS Negl Trop Dis 2010, 4(6):e708.
5. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, Padma S: Antifilarial
drugs, in the doses employed in mass drug administrations by the Global Programme
to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia
malayi infection. Ann Trop Med Parasitol 2009, 103:235-247.
6. Narahari SR, Ryan TJ, Mahadevan PE et al.: Integrated management of filarial
lymphoedema for rural communities. Lymphology 2007, 40:3-13.
7. Narahari SR, Aggithaya GM, Bose KS, Prasanna KS: An Integrative Treatment for Lower
Limb Lymphoedema (Elephantiasis) (photo essay). J Alt Compl Medicine 2010, 16: 145-
149.
8. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD,
Weil GJ: Effect of yearly mass drug administration with diethylcarbamazine and
albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet
2006, 367:992-999.
9. El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, Ramzy RM, Shannon WD,
Weil GJ: The effect of compliance on the impact of mass drug administration for
elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 2007, 77:1069-1073.
10. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Larbi J, Lawson B,
Taylor M, Adjei O, Hoerauf A: Doxycycline reduces plasma VEGF-C/sVEGFR-3 and
improves pathology in lymphatic filariasis. PLoS Pathog 2006, 2:e92.
11. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Lawson B, Taylor M, Adjei O,
Hoerauf A. Reduction in levels of plasma vascular endothelial growth factor-A and
52